Interestingly, EZH2 has previously been characterized as a potent driver of melanoma metastasis with high levels associated with a poor patient prognosis (Bachmann et al., 2006, Fan et al., 2011, Luo et al., 2013, Zingg et al., 2015). The gene discussed is EZH2; the disease is melanoma.